Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Sell
1,895
-61
-3% -$7.14K 0.08% 75
2026
Q1
$235K Buy
+1,956
New +$226K 0.08% 71
2025
Q2
Sell
-2,880
Closed -$258K 80
2025
Q1
$258K Sell
2,880
-1,314
-31% -$123K 0.13% 56
2024
Q4
$417K Sell
4,194
-577
-12% -$59.5K 0.21% 36
2024
Q3
$542K Sell
4,771
-118
-2% -$14K 0.29% 32
2024
Q2
$605K Sell
4,889
-42
-0.9% -$5.41K 0.36% 30
2024
Q1
$651K Sell
4,931
-156
-3% -$19.2K 0.41% 28
2023
Q4
$555K Buy
+5,087
New +$528K 0.25% 32

Other funds holding MRK

Acorn Creek Capital's MRK Position: Q2 2026 in Review

Acorn Creek Capital reduced its Merck (MRK) stake by 3.1% in Q2 2026, selling an estimated $7.14K and leaving 1,895 shares worth $244K. The position accounts for 0.08% of the portfolio, ranked #75.

Acorn Creek Capital first reported a position in MRK in Q4 2023 and has held it in 8 quarters since. The position peaked at $651K in Q1 2024. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Acorn Creek Capital held 1,895 shares of Merck worth $244K as of Q2 2026.
  • Acorn Creek Capital sold 61 Merck shares in Q2 2026, an estimated $7.14K.
  • Merck made up 0.08% of Acorn Creek Capital's portfolio in Q2 2026, its #75 holding.
  • Acorn Creek Capital first reported a position in Merck in Q4 2023 and has held it in 8 quarters since.
  • Acorn Creek Capital's Merck position peaked at $651K in Q1 2024.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Acorn Creek Capital's 13F filing for Q2 2026, filed 6 Aug 2026.